The Journal of Clinical and Translational Research (JCTR) is an open-access, peer-reviewed, multidisciplinary scientific journal that publishes studies with at least an ex vivo, in vivo, or clinical component. The published research centers on any clearly defined clinical problem, which may comprise a disease or the basis of disease, a form of therapy or intervention, and clinical diagnostics or prognostics.
Studies performed in cells only will generally not be accepted unless they contain critical data that are in line with the scope of the journal. Some examples of such studies include molecular pathways that lie at the basis of a disease, novel biotechnological approaches, e.g., the production of drugs, or new techniques that improve clinical diagnostics and prognostics. Articles that combine preclinical and clinical data are given priority. Contributions from academic institutions and industry are welcome.
Articles (original research, reviews, technical reports, medical hypotheses, commissioned articles, special issue articles, and editorials) are published bi-monthly.
Key features
• Open access
• Aarticle processing charge: USD 1000
• Reputable international editorial board
• No word count or reference restrictions
• Double blind review process to minimize bias
• Rapid online publication of articles upon acceptance
• Outlet for academic institutions and industry
Open access policy
JCTR is an open-access journal in which all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking for prior permission from the publisher or the author. It is under the BOAI (Budapest Open Access Initiative) definition of open access.
JCTR articles are open-access articles distributed under the terms of the Creative Commons Attribution License (CC BY-NC 4.0) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Publishing
The Journal of Clinical and Translational Research (JCTR) is published by AccScience Publishing. AccScience Publishing is a sustainable, well-known diversified knowledge service platform.
AccScience Publishing (ASP), founded in Singapore in 2016, is driven by a mission of great significance, that is, to institute a rigorous scientific publishing process, facilitate unrestricted access to scientific knowledge, publish influential academic journals and books, disseminate valuable academic content, and propel scientific innovation. ASP adheres unwaveringly to the COPE publishing guidelines while embracing principles of innovation, collaboration, and knowledge sharing, all in pursuit of maintaining scientific integrity and timeliness.
ASP serves a diverse global community of scholars, committed to freely sharing cutting-edge research under the Creative Commons Attribution (CC BY) license. To enhance the precision, academic rigor, and timeliness of our publications, we have developed the proprietary, cutting-edge manuscript processing system known as the OSS (Online Submission System).
Journal ownership change notice
May 10, 2023
Since May 10, 2023, the ownership of the Journal of Clinical and Translational Research has been transferred from Whioce Publishing to AccScience Publishing. The journal is now under the ownership and management of the new publisher. The Editorial Board remains unchanged.
Publisher office
AccScience Publishing
8 Burn Road#15-03 Trivex Singapore 369977